questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Facteurs de transcription
Facteurs de transcription EGR
Facteurs de transcription EGR : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteurs de transcription EGR : Questions médicales les plus fréquentes",
"headline": "Facteurs de transcription EGR : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteurs de transcription EGR : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-08",
"dateModified": "2025-05-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteurs de transcription EGR"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteurs de transcription",
"url": "https://questionsmedicales.fr/mesh/D014157",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de transcription",
"code": {
"@type": "MedicalCode",
"code": "D014157",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Facteur de transcription EGR-1",
"alternateName": "Early Growth Response Protein 1",
"url": "https://questionsmedicales.fr/mesh/D051766",
"about": {
"@type": "MedicalCondition",
"name": "Facteur de transcription EGR-1",
"code": {
"@type": "MedicalCode",
"code": "D051766",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.213.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur de transcription EGR-2",
"alternateName": "Early Growth Response Protein 2",
"url": "https://questionsmedicales.fr/mesh/D051767",
"about": {
"@type": "MedicalCondition",
"name": "Facteur de transcription EGR-2",
"code": {
"@type": "MedicalCode",
"code": "D051767",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.213.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur de transcription EGR-3",
"alternateName": "Early Growth Response Protein 3",
"url": "https://questionsmedicales.fr/mesh/D051776",
"about": {
"@type": "MedicalCondition",
"name": "Facteur de transcription EGR-3",
"code": {
"@type": "MedicalCode",
"code": "D051776",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.930.213.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de transcription EGR",
"alternateName": "Early Growth Response Transcription Factors",
"code": {
"@type": "MedicalCode",
"code": "D051765",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "John P Lydon",
"url": "https://questionsmedicales.fr/author/John%20P%20Lydon",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA."
}
},
{
"@type": "Person",
"name": "Elizabeth Jose",
"url": "https://questionsmedicales.fr/author/Elizabeth%20Jose",
"affiliation": {
"@type": "Organization",
"name": "Molecular and Cellular Biology, University of Arizona, Tucson, AZ, 85721."
}
},
{
"@type": "Person",
"name": "Woody March-Steinman",
"url": "https://questionsmedicales.fr/author/Woody%20March-Steinman",
"affiliation": {
"@type": "Organization",
"name": "Applied Mathematics, University of Arizona, Tucson, AZ, 85721."
}
},
{
"@type": "Person",
"name": "Lisa Shanks",
"url": "https://questionsmedicales.fr/author/Lisa%20Shanks",
"affiliation": {
"@type": "Organization",
"name": "Molecular and Cellular Biology, University of Arizona, Tucson, AZ, 85721."
}
},
{
"@type": "Person",
"name": "Vineet K Maurya",
"url": "https://questionsmedicales.fr/author/Vineet%20K%20Maurya",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clear Cell Renal Cell Carcinoma: Local Recurrence and Bilateral Adrenal Metastases - A Case Report.",
"datePublished": "2022-05-06",
"url": "https://questionsmedicales.fr/article/35600764",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5334/jbsr.2772"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel cell source for therapy of knee osteoarthritis using atelocollagen microsphere-adhered adipose-derived stem cells: Impact of synovial fluid exposure on cell activity.",
"datePublished": "2024-04-23",
"url": "https://questionsmedicales.fr/article/38694445",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.reth.2024.04.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Machine learning-based integration develops a stress response stated T cell (Tstr)-related score for predicting outcomes in clear cell renal cell carcinoma.",
"datePublished": "2024-04-09",
"url": "https://questionsmedicales.fr/article/38599101",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.intimp.2024.112017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy.",
"datePublished": "2023-12-14",
"url": "https://questionsmedicales.fr/article/38096229",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0295863"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Retracted] Downregulation of ROS‑FIG inhibits cell proliferation, colony‑formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells.",
"datePublished": "2023-12-08",
"url": "https://questionsmedicales.fr/article/38063269",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3892/ijmm.2023.5335"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs de transcription",
"item": "https://questionsmedicales.fr/mesh/D014157"
},
{
"@type": "ListItem",
"position": 5,
"name": "Facteurs de transcription EGR",
"item": "https://questionsmedicales.fr/mesh/D051765"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteurs de transcription EGR - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteurs de transcription EGR",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteurs de transcription EGR",
"description": "Comment diagnostiquer une dysrégulation des EGR ?\nQuels tests sont utilisés pour évaluer les EGR ?\nLes EGR peuvent-ils être mesurés dans le sang ?\nQuels symptômes indiquent une anomalie des EGR ?\nLes EGR sont-ils impliqués dans des maladies spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Cell+Aggregation&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteurs de transcription EGR",
"description": "Quels symptômes sont liés à une surproduction d'EGR ?\nLes EGR affectent-ils le système immunitaire ?\nQuels signes cliniques sont associés aux EGR ?\nLes EGR sont-ils liés à des troubles mentaux ?\nComment les EGR influencent-ils le développement embryonnaire ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Cell+Aggregation&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteurs de transcription EGR",
"description": "Peut-on prévenir les anomalies liées aux EGR ?\nLes facteurs environnementaux influencent-ils les EGR ?\nComment réduire le risque de dysrégulation des EGR ?\nL'exercice physique influence-t-il les EGR ?\nLes suppléments nutritionnels affectent-ils les EGR ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Cell+Aggregation&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteurs de transcription EGR",
"description": "Existe-t-il des traitements ciblant les EGR ?\nComment moduler l'activité des EGR ?\nLes EGR peuvent-ils être une cible pour le cancer ?\nQuels médicaments affectent les EGR ?\nLes EGR sont-ils impliqués dans la thérapie cellulaire ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Cell+Aggregation&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteurs de transcription EGR",
"description": "Quelles complications peuvent survenir avec des EGR anormaux ?\nLes EGR sont-ils liés à des maladies chroniques ?\nComment les EGR affectent-ils la santé cardiovasculaire ?\nLes EGR peuvent-ils causer des troubles neurologiques ?\nQuelles sont les conséquences d'une surproduction d'EGR ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Cell+Aggregation&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteurs de transcription EGR",
"description": "Quels facteurs augmentent le risque de dysrégulation des EGR ?\nLe stress influence-t-il les EGR ?\nL'alimentation joue-t-elle un rôle dans les EGR ?\nLes infections affectent-elles les EGR ?\nL'âge est-il un facteur de risque pour les EGR ?",
"url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Cell+Aggregation&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation des EGR ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses d'expression génique peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les EGR ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les Western blot sont couramment utilisés pour évaluer l'expression des EGR."
}
},
{
"@type": "Question",
"name": "Les EGR peuvent-ils être mesurés dans le sang ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de tests sanguins standardisés pour mesurer les EGR."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une anomalie des EGR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de croissance ou des troubles neurologiques peuvent indiquer une dysrégulation."
}
},
{
"@type": "Question",
"name": "Les EGR sont-ils impliqués dans des maladies spécifiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont associés à des maladies comme le cancer et les troubles neurodégénératifs."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une surproduction d'EGR ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surproduction peut entraîner une hyperplasie cellulaire et des troubles de croissance."
}
},
{
"@type": "Question",
"name": "Les EGR affectent-ils le système immunitaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils régulent la réponse immunitaire et peuvent influencer l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés aux EGR ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la fatigue, des douleurs musculaires et des troubles cognitifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les EGR sont-ils liés à des troubles mentaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent un lien potentiel entre les EGR et des troubles comme la dépression."
}
},
{
"@type": "Question",
"name": "Comment les EGR influencent-ils le développement embryonnaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils jouent un rôle crucial dans la régulation des gènes nécessaires au développement embryonnaire."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies liées aux EGR ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certaines anomalies."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils les EGR ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme le stress et la pollution peuvent affecter leur expression."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de dysrégulation des EGR ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les toxines et maintenir un bon équilibre hormonal peut réduire le risque."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il les EGR ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut moduler l'expression des EGR et améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels affectent-ils les EGR ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les acides gras oméga-3, peuvent influencer leur expression."
}
},
{
"@type": "Question",
"name": "Existe-t-il des traitements ciblant les EGR ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des inhibiteurs spécifiques sont en cours de recherche."
}
},
{
"@type": "Question",
"name": "Comment moduler l'activité des EGR ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents pharmacologiques et des modifications épigénétiques peuvent moduler leur activité."
}
},
{
"@type": "Question",
"name": "Les EGR peuvent-ils être une cible pour le cancer ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les EGR sont des cibles potentielles pour des traitements anticancéreux innovants."
}
},
{
"@type": "Question",
"name": "Quels médicaments affectent les EGR ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments anti-inflammatoires peuvent influencer l'expression des EGR."
}
},
{
"@type": "Question",
"name": "Les EGR sont-ils impliqués dans la thérapie cellulaire ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur régulation est essentielle pour le succès des thérapies cellulaires et régénératives."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des EGR anormaux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme le cancer, les maladies auto-immunes et les troubles métaboliques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les EGR sont-ils liés à des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysrégulation des EGR est associée à des maladies chroniques comme le diabète."
}
},
{
"@type": "Question",
"name": "Comment les EGR affectent-ils la santé cardiovasculaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une régulation anormale des EGR peut contribuer à des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les EGR peuvent-ils causer des troubles neurologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans l'expression des EGR sont liées à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une surproduction d'EGR ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surproduction peut entraîner des tumeurs et des désordres de croissance cellulaire."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dysrégulation des EGR ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'exposition à des toxines et des prédispositions génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les EGR ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter l'expression des EGR et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans les EGR ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut aider à réguler l'expression des EGR."
}
},
{
"@type": "Question",
"name": "Les infections affectent-elles les EGR ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent moduler l'expression des EGR, influençant la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les EGR ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter l'expression des EGR et la régulation génétique."
}
}
]
}
]
}
Clear cell renal cell carcinoma is the most frequent type of renal cell carcinoma, which is often diagnosed incidentally in an advanced stage....
We present the case of a 49-year-old man who presented to the emergency department with no specific symptoms. After computed tomography (CT) evaluation, the suspicion was raised of a left renal tumour...
Clear cell renal cell carcinoma has no specific symptoms. For the complete diagnosis and further monitoring, the use of CT is necessary....
Clear cell renal cell carcinoma treated with partial nephrectomy can relapse near the surgical scar and progress with metachronous bilateral adrenal metastases, especially when close follow-up is not ...
Administration of adipose-derived stem cells (ADSCs) into the joint cavity has been shown to alleviate the symptoms of knee osteoarthritis (OA) by releasing exosomes and anti-inflammatory cytokines. H...
ADSCs were cultured for 2, 4, and 7 days in AMS suspension or adherent culture dishes. The supernatants were analyzed for IL-10 and exosome secretion via enzyme-linked immunosorbent assay and Nanosigh...
Compared with 2D-cultured ADSCs, AMS-cultured ADSCs exhibited a significant increase in secretion of exosomes and IL-10, and the expression of several genes involved in extracellular matrix and immune...
Increased survival of AMS-adhered ADSCs was observed in the intra-articular environment, and AMSs were found to gradually dissipate. These results suggest that AMS-adhered ADSCs are promising source f...
Establishment of a reliable prognostic model and identification of novel biomarkers are urgently needed to develop precise therapy strategies for clear cell renal cell carcinoma (ccRCC). Stress respon...
10 machine-learning algorithms and their combinations were applied in this work. A stable Tstr-related score (TCs) was constructed to predict the outcomes and PD-1 blockade treatment response in ccRCC...
A robust TCs was constructed and validated in four independent cohorts. TCs accurately predicted the prognosis and PD-1 blockade treatment response in ccRCC patients. The novel nomogram was able to pr...
This study provides a Tstr cell-related score for predicting outcomes and PD-1 blockade therapy response in ccRCC. Tstr cells may exert their pro-tumoral role in ccRCC, acting against mast cells, in t...
Immunotherapy is changing the Head and Neck Squamous Cell Carcinoma (HNSCC) landscape and improving outcomes for patients with recurrent or metastatic HNSCC. A deeper understanding of the tumor microe...
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the western blotting data shown in Fig. 9 were strikingly similar to data appearing in differ...
Glioblastoma multiforme (GBM) remains one of the most challenging solid cancers to treat due to its highly aggressive and drug-resistant nature. Flavopiridol is synthetic flavone that was recently app...
Tuberculosis (TB), a zoonosis characterized by chronic respiratory infections, is mainly caused by...
Mesenchymal stem/stromal cells (MSCs) show tremendous potential for regenerative medicine due to their self-renewal, multi-differentiation and immunomodulatory capabilities. Largely studies had indica...
Circular RNA (circRNA) regulates the pathogenesis of acute myeloid leukemia (AML). However, the mechanism of circRNA protein tyrosine kinase 2 (circPTK2) in AML remains unclear....
Quantitative real-time polymerase chain reaction (qRT-PCR) assay was adopted for circPTK2, miR-582-3p and alpha-1,3-mannosyltransferase (ALG3) mRNA levels. 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-...
CircPTK2 level was enhanced in AML peripheral blood samples and cells. CircPTK2 knockdown restrained AML cell proliferation and glycolysis and promoted cell apoptosis and cell cycle arrest. Mechanical...
CircPTK2 contributed to AML cell malignant behaviors by modulation of miR-582-3p/ALG3 axis, which might provide a potential target for AML therapy....
The prognostic characteristics of pancreatic cancer (PC) are determined by the contributing factors from the tumor microenvironment. Leptin is a critical oncogenic factor released by adipocytes as an ...